OTCMKTS:EDTXF Spectral Diagnostics Q1 2026 Earnings Report $0.83 +0.02 (+2.94%) As of 09/29/2026 09:54 AM Eastern ProfileEarnings History Spectral Diagnostics EPS ResultsActual EPS-$0.01Consensus EPS -$0.01Beat/MissMissed by -$0.00One Year Ago EPSN/ASpectral Diagnostics Revenue ResultsActual Revenue$0.64 millionExpected Revenue$0.54 millionBeat/MissBeat by +$99.00 thousandYoY Revenue GrowthN/ASpectral Diagnostics Announcement DetailsQuarterQ1 2026Date5/8/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsSpectral Diagnostics' next earnings date is estimated for Friday, November 6, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Spectral Diagnostics Earnings HeadlinesSpectral Medical Inc EDTXFSeptember 23, 2026 | morningstar.comMSpectral Medical Announces U.S. FDA Filing of PMA Application for PMXJune 25, 2026 | globenewswire.comDr. Ron Paul Issues New Warning: “The Next Financial Crisis Is Here”Dr. Ron Paul warns a dangerous experiment is already underway in Washington, involving at least 27 billion dollars and roughly 30 U.S. companies. Some stocks tied to this shift have already fallen 50% or more, Paul says, as the relationship between government and the stock market changes.September 30 at 1:00 AM | Altimetry (Ad)Spectral Medical Inc. Announces Results of Annual and Special Meeting of ShareholdersJune 9, 2026 | globenewswire.comSpectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral's Tigris TrialJune 4, 2026 | globenewswire.comSpectral Medical Announces PMA Submission to U.S. FDA for PMXMay 29, 2026 | globenewswire.comSee More Spectral Diagnostics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Spectral Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Spectral Diagnostics and other key companies, straight to your email. Email Address About Spectral DiagnosticsSpectral Diagnostics (OTCMKTS:EDTXF), now known as Spectral Medical Inc., is a Canadian medical-device and biotechnology company focused on products for the diagnosis and treatment of sepsis and septic shock. The company’s work centers on identifying endotoxemia, a condition in which bacterial endotoxins enter the bloodstream and can contribute to severe systemic inflammation. Spectral’s primary diagnostic product is the Endotoxin Activity Assay (EAA), a blood test designed to measure a patient’s endotoxin activity and help identify individuals who may be at increased risk of developing severe sepsis. The assay is intended to support physicians in assessing patients and selecting potential treatment strategies. The company has also been involved in the development and commercialization of blood-purification therapies, including polymyxin B hemoperfusion, which is designed to remove endotoxins from the bloodstream. Spectral Medical serves the critical-care and hospital markets, with operations and commercial activities focused primarily in North America and other international markets through regulatory and distribution relationships.View Spectral Diagnostics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles CarMax Just Gave Investors a Better Reason to Believe in the TurnaroundBernstein Downgrades 3 Cybersecurity Stocks: How Concerned Should Investors Be?Brewing Trouble? Starbucks Spills the Beans on 250 Store ClosuresMarketBeat Week in Review – 09/21 - 09/25Analyst Rating Boosts May Signal More Upside for These 3 Stocks3 Stocks Under the Microscope After Large Insider Sales3 Healthcare Stocks Showing Why the Sector Still Has Momentum Upcoming Earnings NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
